Harbin Loctite Pharmaceutical Co., Ltd., Liangjia, a famous trademark in Heilongjiang Province, a well-known brand for the treatment of nail fungus, is a high-tech modern pharmaceutical enterprise integrating scientific research/development/production/sales
Founded in 1996, Harbin Loctite Pharmaceutical Co., Ltd. is a high-tech modern pharmaceutical enterprise integrating scientific research, development, production and sales. It has been assessed and recognized by the Heilongjiang Provincial Food and Drug Administration, and is the key and backbone in the development of new traditional Chinese medicine products and the creation of famous brand enterprises, and has been awarded the title of "high-tech enterprise" by the state. It has already passed GMP certification. Since 2003, it has become a major taxpayer in Hulan District for 10 consecutive years, and is one of the "Top 50 Private Enterprises Paying Taxes" in Harbin. In successive years, it has been awarded many awards such as "Heilongjiang Pharmaceutical Industry Integrity Enterprise", "Heilongjiang Province Contract-abiding and Trustworthy Enterprise", "Excellent Foreign-invested Enterprise", "Advanced Foreign-invested Enterprise in Scientific Management" and "Advanced Foreign-invested Enterprise in Economic Benefits" by Heilongjiang Pharmaceutical Industry Association, provincial and municipal governments at all levels, provincial and municipal Administration for Industry and Commerce at all levels, and China Association of Enterprises with Foreign Investment.
Enterprises have independent intellectual property rights and other intangible assets continue to increase in value. 924 registered trademarks have been declared and accepted, and 659 registered trademarks have been authorized; Nearly 100 product approvals; There are 35 invention patents, and "Liangjia" and a number of product packaging designs have won the national appearance patent project.
The company produces nearly 100 kinds of products including medicines, medical devices, disinfection products, health food, cosmetics, food, etc., including six series of 16 dosage forms, including 13 products independently developed, mainly including: "Liangjia" series, "Kangjiaoya" series, "Ganlebao" series products, cholishu capsules, sugar Taide mixture, barley oral liquid, lumbar pain capsules, Yuke bezoar anti-inflammatory capsules, dressing capsules, wind pain capsules, rhinitis syrup and other products.
The "Liangjia" brand has been awarded the titles of "Well-known Protection", "Famous Trademark of Heilongjiang Province", "China's Top Ten Brands of External Medicine" and "China's Preferred Brand for Consumers in Liangjia Market" issued by the Ministry of Pharmaceutical Industry of China, and "High-tech Products" in Heilongjiang Province. In addition, Cholelishu Capsule was awarded the "First Prize of Scientific and Technological Progress" and "National Product Invention Patent" by the China Federation of Commerce; Liangjia, Leomandan Luohuo Capsule and Cholishu Capsule won the title of "High-tech Product" in Heilongjiang Province and won the "Excellent New Product" award in Heilongjiang Province; "Xiangjiaoya" series of products were rated as "Top 10 Customer Satisfaction Products for Beriberi in Chinese Pharmaceutical Products" by China Market Monitoring Center and China Market Research Center.
In the early stage of the enterprise, with the principle of "high R&D starting point, high scientific and technological content, high clinical efficacy, and great drug safety", the company developed the "Naolotite Capsule (Leotite Capsule)", and quickly put the scientific research results into production, accumulating funds for the development of the enterprise, and was praised as the "Loctite Model" by the Provincial Food and Drug Administration; In 2000, it independently developed a series of high-tech "bright nails" brand products, and created a "new three-stage therapy" to cure nail fungus, solving the global problem of difficult and slow cure of nail fungus. In 2007, the sales of single products exceeded 50 million, and in 2010, the sales of single products exceeded 100 million yuan. Over the past 12 years, the cure rate of nail fungus has reached more than 85%, with a total of more than 10 million nail fungus patients, a sales network covering provinces, cities and towns across the country, with a total sales of 20 million boxes, and nearly 1,000 nail after-sales service centers in 344 cities across the country. At present, "Liangjia" ranks first in the country and has become the first brand in the treatment of nail fungus in China.
